Summary: The Centers for Medicare & Medicaid Services modified its Diagnostic Breath Analyses coverage policy, effective May 15, 2026. Here's what billing teams need to know before claims start hitting denials.
CMS diagnostic breath analyses coverage policy changes affect how Medicare reimburses breath testing procedures used to diagnose conditions like H. pylori infection, small intestinal bacterial overgrowth, and carbohydrate malabsorption. The policy does not list specific CPT or HCPCS codes in the data available at time of publication — but that doesn't make this change low-stakes. Breath test billing is already a claim denial hotspot, and any CMS modification to medical necessity criteria or documentation requirements changes your exposure.
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Diagnostic Breath Analyses |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium |
| Specialties Affected | Gastroenterology, Internal Medicine, Primary Care, Infectious Disease |
| Key Action | Review documentation for all breath test orders and confirm medical necessity criteria align with the updated policy before May 15, 2026 |
CMS Diagnostic Breath Analyses Coverage Criteria and Medical Necessity Requirements 2026
Diagnostic breath testing covers a range of non-invasive procedures. These tests detect metabolic byproducts exhaled by patients to diagnose gastrointestinal conditions. CMS evaluates each test type separately — and that's where billing teams get tripped up.
The real issue with breath test billing is that medical necessity is the hinge point on every claim. CMS requires that documentation clearly support the clinical indication before reimbursement is approved. That means your physician's note needs to spell out why a breath test was ordered over an alternative diagnostic method.
For H. pylori breath testing, CMS has historically covered the urea breath test as a non-invasive alternative to endoscopy when clinical signs point to active infection. The updated coverage policy may refine when that applies — particularly whether prior treatment failure or active symptom presentation is required. If your gastroenterology or primary care team orders these tests routinely without condition-specific documentation, that's your first audit risk.
Lactulose and glucose hydrogen breath tests for small intestinal bacterial overgrowth (SIBO) have faced more scrutiny. Medical necessity documentation for SIBO tests needs to demonstrate that symptoms are consistent with the diagnosis and that less expensive or more established diagnostics were considered. CMS does not rubber-stamp breath testing as a first-line diagnostic tool.
Breath tests for carbohydrate malabsorption — including lactose and fructose hydrogen testing — sit in a similar position. These require documented clinical indication tied to the patient's presenting symptoms and dietary history. Ordering a full panel without individualized clinical rationale increases your claim denial risk significantly.
Whether prior authorization is required for breath testing under Medicare depends on your Medicare Administrative Contractor region. Some MACs have issued local coverage determinations that impose additional requirements on top of the national policy. Check your MAC's LCD for any supplemental criteria that apply in your geographic area. If you're unsure which MAC covers your practice, that's the first call to make before May 15, 2026.
CMS Diagnostic Breath Analyses Exclusions and Non-Covered Indications
The specific codes and detailed exclusions are not listed in the policy data available for this update. That's a gap — and it's worth flagging. When CMS modifies a coverage policy without publishing a clear exclusions list in the accessible policy document, the ambiguity usually resolves at the MAC level through local coverage determinations.
What CMS has consistently excluded from diagnostic breath analysis reimbursement are tests ordered for screening purposes in asymptomatic patients. Breath testing is a diagnostic tool, not a screening tool under Medicare. Ordering a urea breath test for a patient with no gastrointestinal symptoms — even as part of a general wellness panel — is not covered.
Tests that lack sufficient clinical evidence of diagnostic accuracy also fall outside CMS coverage. Some breath test methodologies remain investigational. If your practice uses newer breath testing platforms — particularly those measuring volatile organic compounds for cancer screening or metabolic disorders — those tests may not meet medical necessity under this coverage policy. Confirm with your compliance officer before billing for any breath test that doesn't have an established CPT code tied to it.
Coverage Indications at a Glance
Because the policy data does not include indication-level criteria or specific codes, the table below reflects standard CMS coverage positions for diagnostic breath analyses based on published MAC LCDs and the national coverage policy framework. Verify these against your MAC's current LCD and the updated policy at app.payerpolicy.org before using them for billing decisions.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| H. pylori infection — urea breath test, active diagnosis | Covered | Not specified in policy data | Requires documented clinical signs of active infection; prior authorization requirements vary by MAC |
| Small intestinal bacterial overgrowth (SIBO) — hydrogen/methane breath test | Coverage varies | Not specified in policy data | Medical necessity documentation must support SIBO as the working diagnosis; MAC LCD review required |
| Carbohydrate malabsorption (lactose, fructose) — hydrogen breath test | Coverage varies | Not specified in policy data | Requires clinical indication tied to specific dietary symptoms; full-panel ordering without individualized rationale risks denial |
| Screening in asymptomatic patients | Not Covered | N/A | CMS does not cover breath tests ordered for screening purposes |
| Investigational breath testing (VOC panels, non-established methodologies) | Not Covered / Investigational | N/A | Insufficient clinical evidence; not reimbursable under Medicare |
CMS Diagnostic Breath Analyses Billing Guidelines and Action Items 2026
The effective date is May 15, 2026. That gives your billing team time to act, but not much time to delay. Here's what to do now.
| # | Action Item |
|---|---|
| 1 | Pull your MAC's current LCD for diagnostic breath analyses before April 30, 2026. The Centers for Medicare & Medicaid Services sets the national coverage policy, but your MAC interprets it locally. Any conflict between the modified national policy and your MAC's LCD is something your compliance officer needs to evaluate. Don't wait for a denial to find out there's a gap. |
| 2 | Audit your documentation templates for breath test orders. Every breath test order that hits a Medicare claim needs to show documented medical necessity. That means the clinical indication, the patient's presenting symptoms, and why this test was chosen. Generic language like "rule out GI condition" is not enough. Update your order templates before May 15, 2026. |
| 3 | Confirm which CPT codes your practice uses for breath testing. The updated policy does not list specific codes in the published data. Request the full policy document from your MAC or access it directly at the CMS source. Match every code you're billing to the current coverage criteria. If a code you use isn't addressed in the updated policy, escalate to your compliance officer. |
| 4 | Review your prior authorization workflow for Medicare Advantage patients. This CMS coverage policy applies to traditional Medicare, but Medicare Advantage plans layer their own prior authorization requirements on top. If your practice sees a significant Medicare Advantage volume, check each plan's requirements for breath testing separately. One denial from a MA plan often signals a pattern. |
| 5 | Flag any claims billed after May 15, 2026 that were ordered before the effective date. The date of service governs which policy version applies. If a breath test was ordered in April 2026 but performed in June 2026, the updated policy applies. Make sure your billing team understands that the service date — not the order date — determines coverage. |
| 6 | Talk to your compliance officer if you use non-standard breath testing platforms. Some practices have adopted newer breath testing technologies with limited Medicare coverage history. The modification of this coverage policy is a natural trigger to re-evaluate whether those tests meet current medical necessity standards. Don't assume prior approval means ongoing approval. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Diagnostic Breath Analyses Under CMS Policy
The policy data provided for this update does not include specific CPT, HCPCS, or ICD-10 codes. This is a meaningful gap for billing teams.
For diagnostic breath analyses billing, the applicable codes are typically drawn from the CPT 78000s (nuclear medicine) and the 80000s (pathology and laboratory) depending on the specific test type. H. pylori urea breath testing, hydrogen breath testing for SIBO, and carbohydrate malabsorption testing each have distinct coding pathways — and CMS reimbursement under each pathway depends on the underlying coverage policy criteria.
Do not infer coverage from code existence. A CPT code existing in the fee schedule does not confirm that CMS covers the service for a given indication. Pull the full updated policy directly from the CMS source before updating your charge capture.
Access the full policy at: https://app.payerpolicy.org/p/cms/264-v1
If your MAC has issued an LCD specifically for diagnostic breath analyses, the codes listed there are your primary reference for billing guidelines. Cross-reference those codes against the modified national policy before May 15, 2026.
Get the Full Picture for CPT 78000
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.